DE69837151D1 - Verfahren zur erkennung von transplantabstossungen - Google Patents

Verfahren zur erkennung von transplantabstossungen

Info

Publication number
DE69837151D1
DE69837151D1 DE69837151T DE69837151T DE69837151D1 DE 69837151 D1 DE69837151 D1 DE 69837151D1 DE 69837151 T DE69837151 T DE 69837151T DE 69837151 T DE69837151 T DE 69837151T DE 69837151 D1 DE69837151 D1 DE 69837151D1
Authority
DE
Germany
Prior art keywords
methods
discharges
transplant rejection
detecting transplant
evaluating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837151T
Other languages
English (en)
Other versions
DE69837151T2 (de
Inventor
Terry B Strom
Lauro Vasconcellos
Manikkam Suthanthiran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Beth Israel Deaconess Medical Center Inc
Original Assignee
Cornell Research Foundation Inc
Beth Israel Deaconess Medical Center Inc
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, Beth Israel Deaconess Medical Center Inc, Beth Israel Hospital Association filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of DE69837151D1 publication Critical patent/DE69837151D1/de
Publication of DE69837151T2 publication Critical patent/DE69837151T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • G01N2800/245Transplantation related diseases, e.g. graft versus host disease
DE69837151T 1997-09-24 1998-09-22 Verfahren zur erkennung von transplantabstossungen Expired - Lifetime DE69837151T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US937063 1997-09-24
US08/937,063 US6187534B1 (en) 1997-09-24 1997-09-24 Methods of evaluating transplant rejection
PCT/US1998/019549 WO1999015700A1 (en) 1997-09-24 1998-09-22 Methods of evaluating transplant rejection

Publications (2)

Publication Number Publication Date
DE69837151D1 true DE69837151D1 (de) 2007-04-05
DE69837151T2 DE69837151T2 (de) 2008-01-03

Family

ID=25469437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837151T Expired - Lifetime DE69837151T2 (de) 1997-09-24 1998-09-22 Verfahren zur erkennung von transplantabstossungen

Country Status (10)

Country Link
US (1) US6187534B1 (de)
EP (1) EP1015639B1 (de)
JP (1) JP2001517459A (de)
AT (1) ATE354674T1 (de)
AU (1) AU9493198A (de)
CA (1) CA2304159C (de)
DE (1) DE69837151T2 (de)
ES (1) ES2280103T3 (de)
HK (1) HK1029143A1 (de)
WO (1) WO1999015700A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104371A1 (en) * 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
US6187534B1 (en) 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection
US20070082356A1 (en) * 1997-09-24 2007-04-12 Cornell Research Foundation Inc., a New York, NY corporation Methods of evaluating transplant rejection
US6465215B1 (en) 1999-12-14 2002-10-15 Reneuron Limited Identification of cells for transplantation
GB9925210D0 (en) * 1999-10-25 1999-12-22 Reneuron Ltd Identification of cells for transplantation
US6900015B2 (en) * 2000-04-24 2005-05-31 Beth Israel Deaconess Medical Center, Inc. Measurement of protective genes in allograft rejection
EP1170589A1 (de) * 2000-06-05 2002-01-09 Stichting Sanquin Bloedvoorziening Verfahren zur Histokompatibilitätsuntersuchung
NZ525336A (en) * 2000-10-20 2006-03-31 Expression Diagnostics Inc Leukocyte expression profiling
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
WO2003027242A2 (en) * 2001-09-24 2003-04-03 Duke University Fas ligand
US20030224422A1 (en) * 2002-04-08 2003-12-04 St. Jude Children's Research Hospital, Inc. Pre-and post therapy gene expression profiling to identify drug targets
ATE546547T1 (de) * 2002-08-22 2012-03-15 Novartis Pharma Gmbh Diagnose der chronischen abstossung
AU2003275363A1 (en) * 2002-10-01 2004-04-23 The Johns Hopkins University Use of biomarkers for detecting acute renal transplant rejection
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20070248978A1 (en) * 2006-04-07 2007-10-25 Expression Diagnostics, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
US20070111210A1 (en) * 2003-12-03 2007-05-17 Marc Bigaud Biomarkers for graft rejection
US8053182B2 (en) 2004-01-30 2011-11-08 The Trustees Of The University Of Pennsylvania Predictors of transplant rejection determined by peripheral blood gene-expression profiling
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
GB0419728D0 (en) * 2004-09-06 2004-10-06 Novartis Ag Organic compounds
US7645575B2 (en) * 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2006075682A1 (ja) * 2005-01-13 2006-07-20 Keio University 遺伝子マーカー及びその利用
EP1885889A4 (de) * 2005-05-11 2010-01-20 Expression Diagnostics Inc Verfahren zur überwachung des betriebsstatus von transplantaten über genlisten
WO2006124827A2 (en) * 2005-05-13 2006-11-23 University Of Miami Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease
GB0607943D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
WO2008021431A2 (en) * 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US20080131441A1 (en) 2006-09-26 2008-06-05 Manikkam Suthanthiran Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
US8148067B2 (en) * 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2010105275A2 (en) 2009-03-13 2010-09-16 Cornell University Method to assess human allograft status from microrna expression levels
US9752191B2 (en) 2009-07-09 2017-09-05 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
US9746479B2 (en) 2010-03-09 2017-08-29 Cornell University Methods and compositions to predict and detect acute rejection
WO2014074501A1 (en) * 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
US9758828B2 (en) 2013-01-31 2017-09-12 Cornell University Methods to detect, treat and prevent acute cellular rejection in kidney allografts
US9982301B2 (en) 2014-01-07 2018-05-29 Cornell University Urine mRNA profile and acute dysfunction of kidney allograft
KR101501085B1 (ko) * 2014-05-02 2015-03-12 순천향대학교 산학협력단 돼지 췌장의 발달단계별 차이를 나타내는 단백질을 포함하는 이종기관이식 거부반응 검출을 위한 신규한 항원 및 이를 포함하는 검출용 키트
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213961A (en) 1989-08-31 1993-05-25 Brigham And Women's Hospital Accurate quantitation of RNA and DNA by competetitive polymerase chain reaction
US6187534B1 (en) 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection

Also Published As

Publication number Publication date
ATE354674T1 (de) 2007-03-15
EP1015639A1 (de) 2000-07-05
DE69837151T2 (de) 2008-01-03
US6187534B1 (en) 2001-02-13
JP2001517459A (ja) 2001-10-09
AU9493198A (en) 1999-04-12
CA2304159A1 (en) 1999-04-01
CA2304159C (en) 2012-07-10
ES2280103T3 (es) 2007-09-01
HK1029143A1 (en) 2001-03-23
WO1999015700A1 (en) 1999-04-01
EP1015639B1 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
DE69837151D1 (de) Verfahren zur erkennung von transplantabstossungen
ATE540319T1 (de) Verfahren für die bestimmung von fk506
Watanabe et al. A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood
WO2005023091A3 (en) Method for non-invasive prenatal diagnosis
DE69824004D1 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
WO2004055519A3 (en) Specific markers for pancreatic cancer
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
ES2186926T3 (es) Deteccion de la predisposicion genetica a la retinopatia diabetica amenazante de la vision.
WO2004112570A3 (en) Detection of survivin in the biological fluids of cancer patients
HUP0303888A2 (hu) FKBP-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise
MXPA06014175A (es) Diagnostico o pronostico del curso del cancer de mama.
DK0975800T3 (da) Analyse af nukleotider i opløsning under anvendelse af PNA-prober
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
JP2011526148A (ja) 遺伝子foxP3のTSDR領域のDNAメチル化分析による制御性T細胞のDNAメチル化分析
ATE510927T1 (de) Verfahren zur quantitativen bestimmung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
WO2005005661A3 (en) Genes regulated in ovarian cancer as prognostic and therapeutic targets
ATE308755T1 (de) Pränatale diagnostische verfahren in vitro
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
DE60025336D1 (de) Verfahren und kit zur früherkennung von krebs
HUP0303890A2 (hu) Differenciációs nukleinsavak és polipeptidek inhibitorának prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition